Key facts
- Notable investors include ACC Bioscience Incubator, O&G Technologies.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for 16s technologies
- ·The full record, as it builds
Funding rounds
No funding rounds for 16s technologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About 16s technologies
Developer of chemical mitigation optimization technologies designed to prevent corrosion-causing microorganisms from reaching problematic levels. The company focuses on DNA sequencing, precision microbial control, and actionable data analytics to improve biocide efficiency and reduce chemical spending across upstream, midstream, and downstream sectors, enabling businesses to enhance microbial control and reduce costs.
- Sector
- Business Products and Services (B2B)
- HQ
- Austin, TX, United States
- Founded
- 2016
- Employees
- 2
- Website
- 16stechnologies.com/
- Ownership
- Privately Held (backing)
16s technologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in 16s technologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on 16s technologies in its N-PORT filings yet. We sweep new filings monthly.